nelarabine

Product NDC
81927-111
11-digit product format
819270111
Labeler code
81927
Product ID
81927-111_f21b358e-9f41-4dc3-858f-b55f9a8af715
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
nelarabine
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Shorla Oncology Inc.
Application
ANDA214809
Marketing category
ANDA
Marketing start
2023-03-15
Substance
NELARABINE
Active strength
5 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
nelarabine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NELARABINE5 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii60158CV180
Rxcui603566, 2722411

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
68e3b4d6-92e5-2b85-ee38-af06171b640cProduct name620250331

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81927-111-01nelarabine50 mL in 1 VIAL, SINGLE-DOSEINJECTION506
81927-111-01nelarabine1 in 1 CARTONINJECTION16
81927-111-06nelarabine6 in 1 CARTONINJECTION66
81927-111-06nelarabine50 mL in 1 VIAL, SINGLE-DOSEINJECTION506

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
81927-111-01ML - Milliliter81927-11120d83d4b-121a-47a7-8849-2af2bfc8262f12023-04-07
81927-111-06ML - Milliliter81927-11130d65b67-7d05-4706-9046-0ff64416ce6a12023-04-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81927-111NELARABINE INJECTION [SHORLA ONCOLOGY INC.]3Current NDC, 4 package rows20250430_fc401b06-4e3b-413e-a854-3e031c433862.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
603566nelarabine 250 MG in 50 ML InjectionPSNfc401b06-4e3b-413e-a854-3e031c4338626
2722411nelarabine 375 MG in 75 ML InjectionPSNfc401b06-4e3b-413e-a854-3e031c4338626
60356650 ML nelarabine 5 MG/ML InjectionSCDfc401b06-4e3b-413e-a854-3e031c4338626
272241175 ML nelarabine 5 MG/ML InjectionSCDfc401b06-4e3b-413e-a854-3e031c4338626
603566nelarabine 250 MG per 50 ML InjectionSYfc401b06-4e3b-413e-a854-3e031c4338626
2722411nelarabine 375 MG per 75 ML InjectionSYfc401b06-4e3b-413e-a854-3e031c4338626

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
81927-111-01819270111011 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-01) / 50 mL in 1 VIAL, SINGLE-DOSE2023-03-15NoNoHistorical
81927-111-06819270111066 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-06) / 50 mL in 1 VIAL, SINGLE-DOSE2023-03-15NoNoHistorical